Smartleaf Asset Management LLC grew its position in Cushman & Wakefield plc (NYSE:CWK – Free Report) by 264.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,709 shares of the company’s stock after purchasing an additional 2,691 shares during the period. Smartleaf Asset Management LLC’s holdings in Cushman & Wakefield were worth $48,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of CWK. Vaughan Nelson Investment Management L.P. lifted its position in Cushman & Wakefield by 9.6% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 12,474,380 shares of the company’s stock valued at $163,164,000 after buying an additional 1,094,260 shares in the last quarter. State Street Corp raised its stake in shares of Cushman & Wakefield by 9.8% in the 3rd quarter. State Street Corp now owns 8,463,595 shares of the company’s stock valued at $115,359,000 after acquiring an additional 756,966 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Cushman & Wakefield by 7.5% during the 3rd quarter. Geode Capital Management LLC now owns 5,696,370 shares of the company’s stock valued at $77,656,000 after acquiring an additional 395,652 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in Cushman & Wakefield by 8.2% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,975,566 shares of the company’s stock worth $54,187,000 after purchasing an additional 301,186 shares during the period. Finally, WCM Investment Management LLC increased its holdings in Cushman & Wakefield by 3.4% in the 3rd quarter. WCM Investment Management LLC now owns 2,534,105 shares of the company’s stock valued at $34,591,000 after purchasing an additional 84,002 shares in the last quarter. Hedge funds and other institutional investors own 95.56% of the company’s stock.
Cushman & Wakefield Stock Down 0.5 %
Shares of NYSE CWK opened at $11.15 on Tuesday. The company has a debt-to-equity ratio of 1.67, a quick ratio of 1.18 and a current ratio of 1.15. Cushman & Wakefield plc has a 1 year low of $9.24 and a 1 year high of $16.11. The stock’s 50-day simple moving average is $12.71 and its 200-day simple moving average is $13.35. The firm has a market cap of $2.56 billion, a price-to-earnings ratio of 20.27 and a beta of 1.40.
Wall Street Analyst Weigh In
A number of research analysts have commented on CWK shares. JPMorgan Chase & Co. boosted their price objective on Cushman & Wakefield from $14.00 to $17.00 and gave the stock a “neutral” rating in a research note on Monday, December 16th. Jefferies Financial Group lowered Cushman & Wakefield from a “buy” rating to a “hold” rating and reduced their price target for the stock from $18.00 to $14.00 in a research report on Thursday, January 2nd. Finally, The Goldman Sachs Group decreased their price target on Cushman & Wakefield from $14.50 to $13.00 and set a “sell” rating for the company in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $15.00.
Read Our Latest Research Report on CWK
Cushman & Wakefield Company Profile
Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.
Featured Stories
- Five stocks we like better than Cushman & Wakefield
- Do ETFs Pay Dividends? What You Need to Know
- How to Protect Your Portfolio When Inflation Is Rising
- What is the Dow Jones Industrial Average (DJIA)?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Where Do I Find 52-Week Highs and Lows?
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Cushman & Wakefield Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cushman & Wakefield and related companies with MarketBeat.com's FREE daily email newsletter.